mRNA brought to you by DARPA; Same people who invented the internet&pretty much everything

At DARPA, program managers come from outside DARPA, do time within the organization on specific projects, and then return to other places in government, academia or the private sector. In the process of doing that, they enrich both DARPA and the organization from which they came.

Stefanie Tompkins, DARPA's director, said A recent example of the value of DARPA is with the fight against COVID-19. When she was serving at DARPA about five years ago, she said she often discussed ongoing investments and work DARPA had been involved in regarding messenger RNA vaccines. Messenger RNA, or mRNA, induces the body to produce some harmless spike protein, enough to prime the immune system to react if it later encounters the real virus.

"mRNA vaccines are pretty much a household word today, but at the time, they were much, much more obscure," she said.
The DARPA investments in mRNA vaccines at the time were based on insight from forward-thinking program managers who saw value in mRNA vaccines for both military use and for public health applications, she said.

"The research that DARPA first initiated more than a decade ago is now playing a leading and catalytic role in today's fight against COVID-19," she said.

[link to www.defense.gov (secure)]

mRNA is part of biology. They didn't invent it. They hijacked it.

At DARPA, program managers come from outside DARPA, do time within the organization on specific projects, and then return to other places in government, academia or the private sector. In the process of doing that, they enrich both DARPA and the organization from which they came.

Stefanie Tompkins, DARPA's director, said A recent example of the value of DARPA is with the fight against COVID-19. When she was serving at DARPA about five years ago, she said she often discussed ongoing investments and work DARPA had been involved in regarding messenger RNA vaccines. Messenger RNA, or mRNA, induces the body to produce some harmless spike protein, enough to prime the immune system to react if it later encounters the real virus.

"mRNA vaccines are pretty much a household word today, but at the time, they were much, much more obscure," she said.
The DARPA investments in mRNA vaccines at the time were based on insight from forward-thinking program managers who saw value in mRNA vaccines for both military use and for public health applications, she said.

"The research that DARPA first initiated more than a decade ago is now playing a leading and catalytic role in today's fight against COVID-19," she said.

[link to www.defense.gov (secure)]

At DARPA, program managers come from outside DARPA, do time within the organization on specific projects, and then return to other places in government, academia or the private sector. In the process of doing that, they enrich both DARPA and the organization from which they came.

Stefanie Tompkins, DARPA's director, said A recent example of the value of DARPA is with the fight against COVID-19. When she was serving at DARPA about five years ago, she said she often discussed ongoing investments and work DARPA had been involved in regarding messenger RNA vaccines. Messenger RNA, or mRNA, induces the body to produce some harmless spike protein, enough to prime the immune system to react if it later encounters the real virus.

"mRNA vaccines are pretty much a household word today, but at the time, they were much, much more obscure," she said.
The DARPA investments in mRNA vaccines at the time were based on insight from forward-thinking program managers who saw value in mRNA vaccines for both military use and for public health applications, she said.

"The research that DARPA first initiated more than a decade ago is now playing a leading and catalytic role in today's fight against COVID-19," she said.

[link to www.defense.gov (secure)]

DARPA is a front for the Umbrella Corporation.

Kimberly Ann Goguen said so.

Removing the Viral Threat: Two Months to Stop Pandemic X from Taking Hold (2017)

DARPA aims to develop an integrated end-to-end platform that uses nucleic acid sequences to halt the spread of viral infections in sixty days or less

Over the past several years, DARPA-funded researchers have pioneered RNA vaccine technology, a medical countermeasure against infectious diseases that uses coded genetic constructs to stimulate production of viral proteins in the body, which in turn can trigger a protective antibody response. As a follow-on effort, DARPA funded research into genetic constructs that can directly stimulate production of antibodies in the body.1,2 DARPA is now launching the Pandemic Prevention Platform (P3) program, aimed at developing that foundational work into an entire system capable of halting the spread of any viral disease outbreak before it can escalate to pandemic status. Such a capability would offer a stark contrast to the state of the art for developing and deploying traditional vaccines—a process that does not deliver treatments to patients until months, years, or even decades after a viral threat emerges.

“DARPA’s goal is to create a technology platform that can place a protective treatment into health providers’ hands within 60 days of a pathogen being identified, and have that treatment induce protection in patients within three days of administration. We need to be able to move at this speed considering how quickly outbreaks can get out of control,” said Matt Hepburn, the P3 Program Manager. “The technology needs to work on any viral disease, whether it’s one humans have faced before or not.”

Recent outbreaks of viral infectious diseases such as Zika, H1N1 influenza, and Ebola have cast into sharp relief the inability of the global health system to rapidly contain the spread of a disease using existing tools and procedures. State-of-the-art medical countermeasures typically take many months or even years to develop, produce, distribute, and administer. These solutions often arrive too late—if at all—and in quantities too small to respond to emerging threats. In contrast, the envisioned P3 platform would cut response time to weeks and stay within the window of relevance for containing an outbreak.

Key to this undertaking are nucleic-acid-based technologies—those that are centered on DNA and RNA—including some developed under DARPA’s Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program. Using these tools, scientists can identify protective antibodies from recovering patients and then, through a biological version of reverse engineering, manufacture genetic constructs that, when delivered, can instruct an individual’s body to produce similar protective antibodies. Significant quantities of these nucleic acid “blueprints” can be rapidly manufactured compared to state-of-the-art antibody production methods.

less than 50%
[link to www.darpa.mil (secure)]

Army General to Co-Lead 'Operation Warp Speed' for COVID-19 Vaccine

[link to www.defense.gov (secure)]

At DARPA, program managers come from outside DARPA, do time within the organization on specific projects, and then return to other places in government, academia or the private sector. In the process of doing that, they enrich both DARPA and the organization from which they came.

Stefanie Tompkins, DARPA's director, said A recent example of the value of DARPA is with the fight against COVID-19. When she was serving at DARPA about five years ago, she said she often discussed ongoing investments and work DARPA had been involved in regarding messenger RNA vaccines. Messenger RNA, or mRNA, induces the body to produce some harmless spike protein, enough to prime the immune system to react if it later encounters the real virus.

"mRNA vaccines are pretty much a household word today, but at the time, they were much, much more obscure," she said.
The DARPA investments in mRNA vaccines at the time were based on insight from forward-thinking program managers who saw value in mRNA vaccines for both military use and for public health applications, she said.

"The research that DARPA first initiated more than a decade ago is now playing a leading and catalytic role in today's fight against COVID-19," she said.

[link to www.defense.gov (secure)]

No one person "Invented" the web. It evolved. I cant give away who I am but my Father helped "invent" the internet. He also had a patent on a hand held wifi device in the 1960s.

The internet was in Universities by the 1950s. Libraries and research scientists were the first to get them. My Uncle owned one of the first computers when they took up entire floors of buildings.

They claim we sent Man to the moon on 8MB computer. Ridiculous.

It dosent work!!

That’s the fun part.

Gene editing and transfection only kills.

As you will see.

No no no.

Didn't you hear?

Blacks invented everything.